A Double-Blind Randomized, Placebo-Controlled, Dose Escalating Study to Assess The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of ADC3680B Administered Orally to Healthy Volunteers and to Investigate Food Effects on Pharmacokinetics After Single Oral Doses of ADC3680B.

Trial Profile

A Double-Blind Randomized, Placebo-Controlled, Dose Escalating Study to Assess The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of ADC3680B Administered Orally to Healthy Volunteers and to Investigate Food Effects on Pharmacokinetics After Single Oral Doses of ADC3680B.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jan 2013

At a glance

  • Drugs ADC 3680 (Primary)
  • Indications Acute asthma; Chronic obstructive pulmonary disease
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Feb 2011 Actual end date (February 2011) added as reported by ClinicalTrials.gov.
    • 14 Aug 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top